According to our new research study on “Anti-obesity Drugs Market Forecast to 2031 -Global Analysis - by Type, Drug Class, Route of Administration, Application, Distribution Channel, and Geography,” the market is anticipated to grow from US$ 15.85 billion in 2024 and is projected to reach US$ 177.27 billion by 2031; it is expected to register a CAGR of 35.3% during 2025-2031. ![Anti-obesity Drugs Market]( "Anti-obesity Drugs Market")
Mounting prevalence of obesity and increased awareness and demand for weight management solutions are contributing to the growing anti-obesity drugs market size. However, the side effects and safety concerns hamper the anti-obesity drugs market growth. Further, precision medicine and personalized anti-obesity drug regimens is expected to bring in new anti-obesity drugs market trends in the coming years.
In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for anti-obesity drugs in the world. Chronic wounds associated with diabetes include foot, venous, and pressure ulcers. According to The International Journal of Tissue Repair and Regeneration, active or healed venous ulcers occur in 1% of the US population. As per the National Diabetes Statistics Report 2020, a publication of the Centers for Disease Control and Prevention (CDC), 34.2 million people of all ages in the US have diabetes, and ~1 million diabetics develop a foot ulcer each year, while 6-7 million diabetes patients develop ulcers in their lifetime.
Thus, the rising incidence of diabetes and chronic wounds leads to an increase in demand for wound dressing and contributes to the anti-obesity drugs market growth during the forecast period. Companies in the US are focused on expanding their presence by adopting organic and inorganic strategies. In October 2021, Medline Industries announced an investment of US$ 77.5 million to build a new distribution center in Kansas.
Anti-obesity Drugs Market Analysis
Expansion in Emerging Economies to Provide Market Opportunities in Future
According to a Lancet study published in July 2023, approximately 450 million adults in India are expected to be overweight or obese by 2050. In 2021, more than half of the world's adults who were classified as overweight or obese lived in India, with 180 million affected individuals; China, with 402 million; Brazil, with 88 million; Russia, with 71 million; Mexico, with 58 million; Indonesia, with 52 million; and Egypt, with 41 million.
According to the World Obesity Federation, Vietnam, Indonesia, and Bangladesh are experiencing rising obesity prevalence, with a rate of 6-9% in recent decades. The mounting prevalence of obesity in emerging countries due to urbanization, sedentary lifestyles, and dietary changes has increased the demand for anti-obesity drugs. A large segment of the population remains undiagnosed or untreated, offering an underpenetrated market for pharmaceutical companies to introduce new therapies and expand their reach. Eli Lilly is preparing to launch its weight-loss and diabetes drug, tirzepatide (marketed as Mounjaro for diabetes and Zepbound for obesity), in India, Brazil, and Mexico by 2026.
Brazil is enhancing healthcare infrastructure and obesity management programs, fostering a supportive environment for the introduction and reimbursement of new anti-obesity medications. In April 2024, Brazil opened a laboratory in Hortolândia, São Paulo State, dedicated to producing medications for diabetes and obesity, including liraglutide, an active ingredient found in Ozempic.
The EMS-operated plant will also produce semaglutide, a key ingredient in Ozempic, which has a patent valid until March 2026 and is already under review by Agência Nacional de Vigilância Sanitária (ANVISA). With an investment of R$60 million (~US$ 10.93 million), this facility is the first of its kind in Brazil and supports the federal government's Health Economic-Industrial Complex initiatives.
According to the World Economic Forum, initial access to anti-obesity medications may be limited to private markets and out-of-pocket payments. Still, future insurance coverage and generic versions in middle-income countries could improve the accessibility of these medications. Thus, the rising obesity rates, supportive government initiatives, and product innovations are expected to create future growth opportunities for the market in emerging countries.
Anti-obesity Drugs Market Report Segmentation Analysis
Key segments that contributed to the derivation of the anti-obesity drugs market analysis are type, drug class, route of administration, application, and distribution channel.
Anti-obesity Drugs Market: Competitive Landscape and Key Developments
Novo Nordisk AS, Eli Lilly and Co, GSK Plc, Rhythm Pharmaceuticals Inc, Currax Pharmaceuticals LLC., VIVUS LLC, AdvaCare Pharma USA LL, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, and F. Hoffmann-La Roche Ltd are among the key companies operating in the anti-obesity drugs market.
The World Health Organization, World Obesity Atlas, The U.S. Food and Drug Administration, The Lancet Journal, World Obesity Federation, World Economic Forum, Centers for Disease Control and Prevention (CDC), the International Diabetes Federation (IDF), the Organization for Economic Co-operation and Development (OECD) are primary and secondary sources referred to while preparing the anti-obesity drugs market report.
Reasons to Buy
Mounting prevalence of obesity and increased awareness and demand for weight management solutions are contributing to the growing anti-obesity drugs market size. However, the side effects and safety concerns hamper the anti-obesity drugs market growth. Further, precision medicine and personalized anti-obesity drug regimens is expected to bring in new anti-obesity drugs market trends in the coming years.
In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for anti-obesity drugs in the world. Chronic wounds associated with diabetes include foot, venous, and pressure ulcers. According to The International Journal of Tissue Repair and Regeneration, active or healed venous ulcers occur in 1% of the US population. As per the National Diabetes Statistics Report 2020, a publication of the Centers for Disease Control and Prevention (CDC), 34.2 million people of all ages in the US have diabetes, and ~1 million diabetics develop a foot ulcer each year, while 6-7 million diabetes patients develop ulcers in their lifetime.
Thus, the rising incidence of diabetes and chronic wounds leads to an increase in demand for wound dressing and contributes to the anti-obesity drugs market growth during the forecast period. Companies in the US are focused on expanding their presence by adopting organic and inorganic strategies. In October 2021, Medline Industries announced an investment of US$ 77.5 million to build a new distribution center in Kansas.
Anti-obesity Drugs Market Analysis
Expansion in Emerging Economies to Provide Market Opportunities in Future
According to a Lancet study published in July 2023, approximately 450 million adults in India are expected to be overweight or obese by 2050. In 2021, more than half of the world's adults who were classified as overweight or obese lived in India, with 180 million affected individuals; China, with 402 million; Brazil, with 88 million; Russia, with 71 million; Mexico, with 58 million; Indonesia, with 52 million; and Egypt, with 41 million.
According to the World Obesity Federation, Vietnam, Indonesia, and Bangladesh are experiencing rising obesity prevalence, with a rate of 6-9% in recent decades. The mounting prevalence of obesity in emerging countries due to urbanization, sedentary lifestyles, and dietary changes has increased the demand for anti-obesity drugs. A large segment of the population remains undiagnosed or untreated, offering an underpenetrated market for pharmaceutical companies to introduce new therapies and expand their reach. Eli Lilly is preparing to launch its weight-loss and diabetes drug, tirzepatide (marketed as Mounjaro for diabetes and Zepbound for obesity), in India, Brazil, and Mexico by 2026.
Brazil is enhancing healthcare infrastructure and obesity management programs, fostering a supportive environment for the introduction and reimbursement of new anti-obesity medications. In April 2024, Brazil opened a laboratory in Hortolândia, São Paulo State, dedicated to producing medications for diabetes and obesity, including liraglutide, an active ingredient found in Ozempic.
The EMS-operated plant will also produce semaglutide, a key ingredient in Ozempic, which has a patent valid until March 2026 and is already under review by Agência Nacional de Vigilância Sanitária (ANVISA). With an investment of R$60 million (~US$ 10.93 million), this facility is the first of its kind in Brazil and supports the federal government's Health Economic-Industrial Complex initiatives.
According to the World Economic Forum, initial access to anti-obesity medications may be limited to private markets and out-of-pocket payments. Still, future insurance coverage and generic versions in middle-income countries could improve the accessibility of these medications. Thus, the rising obesity rates, supportive government initiatives, and product innovations are expected to create future growth opportunities for the market in emerging countries.
Anti-obesity Drugs Market Report Segmentation Analysis
Key segments that contributed to the derivation of the anti-obesity drugs market analysis are type, drug class, route of administration, application, and distribution channel.
- Based on type, the anti-obesity drugs market is bifurcated into prescription and OTC. The prescription segment held relatively larger share of the market in 2024.
- By drug class, the anti-obesity drugs market is segmented into GLP-1 agonists, lipase inhibitors, MC4R agonists, and others. The GLP-1 Agonist segment held the largest share of the market in 2024. GLP-1 agonists segment further subsegmented into Semaglutide, Liraglutide, Tirzepatide.
- Based on application, the anti-obesity drugs market is categorized into appetite suppression, inhibition of fat absorption/digestive enzymes, metabolic enhancement, and combination. The appetite suppression segment held a largest share of the market in 2024.
- In terms of route of administration, the anti-obesity drugs market is bifurcated into oral and parenteral. The oral segment dominated the market in 2024.
- Per distribution channel, the anti-obesity drugs market is categorized into hospital pharmacies, online channel, and retail pharmacies. The hospital pharmacies segment dominated the market in 2024.
Anti-obesity Drugs Market: Competitive Landscape and Key Developments
Novo Nordisk AS, Eli Lilly and Co, GSK Plc, Rhythm Pharmaceuticals Inc, Currax Pharmaceuticals LLC., VIVUS LLC, AdvaCare Pharma USA LL, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, and F. Hoffmann-La Roche Ltd are among the key companies operating in the anti-obesity drugs market.
The World Health Organization, World Obesity Atlas, The U.S. Food and Drug Administration, The Lancet Journal, World Obesity Federation, World Economic Forum, Centers for Disease Control and Prevention (CDC), the International Diabetes Federation (IDF), the Organization for Economic Co-operation and Development (OECD) are primary and secondary sources referred to while preparing the anti-obesity drugs market report.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the anti-obesity drugs market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the anti-obesity drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Anti-Obesity Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2 PEST Analysis
5. Anti-Obesity Drugs Market - Key Market Dynamics
5.1 Anti-Obesity Drugs Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Mounting Prevalence of Obesity
5.2.2 Increased Awareness and Demand for Weight Management Solutions
5.3 Market Restraints
5.3.1 Side Effects and Safety Concerns
5.4 Market Opportunities
5.4.1 Expansion in Emerging Economies
5.5 Future Trends
5.5.1 Precision Medicine and Personalized Anti-Obesity Drug Regimens
5.6 Impact of Drivers and Restraints:
5.2 Market Drivers
5.2.1 Mounting Prevalence of Obesity
5.2.2 Increased Awareness and Demand for Weight Management Solutions
5.3 Market Restraints
5.3.1 Side Effects and Safety Concerns
5.4 Market Opportunities
5.4.1 Expansion in Emerging Economies
5.5 Future Trends
5.5.1 Precision Medicine and Personalized Anti-Obesity Drug Regimens
5.6 Impact of Drivers and Restraints:
6. Anti-Obesity Drugs Market - Global Market Analysis
6.1 Anti-Obesity Drugs Market Revenue (US$ Million), 2021-2031
6.2 Anti-Obesity Drugs Market Forecast Analysis
6.2 Anti-Obesity Drugs Market Forecast Analysis
7. Anti-Obesity Drugs Market Analysis - by Type
7.1 Prescription Drugs
7.1.1 Overview
7.1.2 Prescription Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.2 OTC Drugs
7.2.1 Overview
7.2.2 OTC Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.1.1 Overview
7.1.2 Prescription Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
7.2 OTC Drugs
7.2.1 Overview
7.2.2 OTC Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8. Anti-Obesity Drugs Market Analysis - by Drug Class
8.1 GLP-1 Agonist
8.1.1 Overview
8.1.2 GLP-1 Agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Lipase Inhibitors
8.2.1 Overview
8.2.2 Lipase Inhibitors: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.3 MC4R agonist
8.3.1 Overview
8.3.2 MC4R agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1 Overview
8.1.2 GLP-1 Agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Lipase Inhibitors
8.2.1 Overview
8.2.2 Lipase Inhibitors: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.3 MC4R agonist
8.3.1 Overview
8.3.2 MC4R agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9. Anti-Obesity Drugs Market Analysis - by Application
9.1 Appetite Suppression
9.1.1 Overview
9.1.2 Appetite Suppression: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Inhibition of Fat Absorption or Digestive Enzymes
9.2.1 Overview
9.2.2 Inhibition of Fat Absorption or Digestive Enzymes: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Metabolic Enhancement
9.3.1 Overview
9.3.2 Metabolic Enhancement: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Combination
9.4.1 Overview
9.4.2 Combination: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1 Overview
9.1.2 Appetite Suppression: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Inhibition of Fat Absorption or Digestive Enzymes
9.2.1 Overview
9.2.2 Inhibition of Fat Absorption or Digestive Enzymes: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Metabolic Enhancement
9.3.1 Overview
9.3.2 Metabolic Enhancement: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Combination
9.4.1 Overview
9.4.2 Combination: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10. Anti-Obesity Drugs Market Analysis - by Route Of Administration
10.1 Oral
10.1.1 Overview
10.1.2 Oral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Parenteral
10.2.1 Overview
10.2.2 Parenteral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.1.1 Overview
10.1.2 Oral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Parenteral
10.2.1 Overview
10.2.2 Parenteral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11. Anti-Obesity Drugs Market Analysis - by Distribution Channel
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Online Channel
11.2.1 Overview
11.2.2 Online Channel: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Retail Pharmacies
11.3.1 Overview
11.3.2 Retail Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.1.1 Overview
11.1.2 Hospital Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Online Channel
11.2.1 Overview
11.2.2 Online Channel: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Retail Pharmacies
11.3.1 Overview
11.3.2 Retail Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
12. Anti-Obesity Drugs Market - Geographical Analysis
12.1 Overview
12.2 North America
12.2.1 North America Anti-Obesity Drugs Market Overview
12.2.2 North America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.2.3 North America: Anti-Obesity Drugs Market Breakdown, by Type
12.2.3.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.2.4 North America: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.4.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.2.4.1.1 North America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.5 North America: Anti-Obesity Drugs Market Breakdown, by Application
12.2.5.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.2.6 North America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.6.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.2.7 North America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.2.7.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.2.8 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.2.8.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.2.8.2 United States: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.8.2.1 United States: Anti-Obesity Drugs Market Breakdown, by Type
12.2.8.2.2 United States: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.8.2.2.1 United States: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.8.2.3 United States: Anti-Obesity Drugs Market Breakdown, by Application
12.2.8.2.4 United States: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.8.2.5 United States: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.2.8.3 Canada: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.8.3.1 Canada: Anti-Obesity Drugs Market Breakdown, by Type
12.2.8.3.2 Canada: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.8.3.2.1 Canada: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.8.3.3 Canada: Anti-Obesity Drugs Market Breakdown, by Application
12.2.8.3.4 Canada: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.8.3.5 Canada: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.2.8.4 Mexico: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.8.4.1 Mexico: Anti-Obesity Drugs Market Breakdown, by Type
12.2.8.4.2 Mexico: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.8.4.2.1 Mexico: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.8.4.3 Mexico: Anti-Obesity Drugs Market Breakdown, by Application
12.2.8.4.4 Mexico: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.8.4.5 Mexico: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3 Europe
12.3.1 Europe Anti-Obesity Drugs Market Overview
12.3.2 Europe: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.3.3 Europe: Anti-Obesity Drugs Market Breakdown, by Type
12.3.3.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.3.4 Europe: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.4.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.3.4.1.1 Europe: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.5 Europe: Anti-Obesity Drugs Market Breakdown, by Application
12.3.5.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.3.6 Europe: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.6.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.3.7 Europe: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.7.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.3.8 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.3.8.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.3.8.2 Germany: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.2.1 Germany: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.2.2 Germany: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.2.2.1 Germany: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.2.3 Germany: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.2.4 Germany: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.2.5 Germany: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.3 United Kingdom: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.3.1 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.3.2 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.3.2.1 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.3.3 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.3.4 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.3.5 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.4 France: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.4.1 France: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.4.2 France: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.4.2.1 France: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.4.3 France: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.4.4 France: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.4.5 France: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.5 Spain: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.5.1 Spain: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.5.2 Spain: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.5.2.1 Spain: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.5.3 Spain: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.5.4 Spain: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.5.5 Spain: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.6 Italy: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.6.1 Italy: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.6.2 Italy: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.6.2.1 Italy: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.6.3 Italy: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.6.4 Italy: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.6.5 Italy: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.7 Rest of Europe: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.7.1 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.7.2 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.7.2.1 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.7.3 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.7.4 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.7.5 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4 Asia Pacific
12.4.1 Asia Pacific Anti-Obesity Drugs Market Overview
12.4.2 Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.4.3 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Type
12.4.3.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.4.4 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.4.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.4.4.1.1 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.5 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Application
12.4.5.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.4.6 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.6.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.4.7 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.7.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.4.8 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.4.8.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.4.8.2 China: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.2.1 China: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.2.2 China: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.2.2.1 China: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.2.3 China: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.2.4 China: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.2.5 China: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.3 Japan: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.3.1 Japan: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.3.2 Japan: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.3.2.1 Japan: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.3.3 Japan: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.3.4 Japan: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.3.5 Japan: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.4 India: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.4.1 India: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.4.2 India: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.4.2.1 India: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.4.3 India: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.4.4 India: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.4.5 India: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.5 Australia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.5.1 Australia: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.5.2 Australia: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.5.2.1 Australia: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.5.3 Australia: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.5.4 Australia: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.5.5 Australia: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.6 South Korea: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.6.1 South Korea: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.6.2 South Korea: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.6.2.1 South Korea: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.6.3 South Korea: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.6.4 South Korea: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.6.5 South Korea: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.7 Rest of APAC: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.7.1 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.7.2 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.7.2.1 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.7.3 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.7.4 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.7.5 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5 Middle East and Africa
12.5.1 Middle East and Africa Anti-Obesity Drugs Market Overview
12.5.2 Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.5.3 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Type
12.5.3.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.5.4 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.4.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.5.4.1.1 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.5 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Application
12.5.5.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.5.6 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.6.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.5.7 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.7.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.5.8 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.5.8.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.5.8.2 Saudi Arabia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.2.1 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.2.2 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.2.2.1 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.2.3 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.2.4 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.2.5 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.8.3 South Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.3.1 South Africa: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.3.2 South Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.3.2.1 South Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.3.3 South Africa: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.3.4 South Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.3.5 South Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.8.4 United Arab Emirates: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.4.1 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.4.2 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.4.2.1 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.4.3 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.4.4 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.4.5 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.8.5 Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.5.1 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.5.2 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.5.2.1 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.5.3 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.5.4 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.5.5 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6 South and Central America
12.6.1 South and Central America Anti-Obesity Drugs Market Overview
12.6.2 South and Central America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.6.3 South and Central America: Anti-Obesity Drugs Market Breakdown, by Type
12.6.3.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.6.4 South and Central America: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.4.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.6.4.1.1 South and Central America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.5 South and Central America: Anti-Obesity Drugs Market Breakdown, by Application
12.6.5.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.6.6 South and Central America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.6.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.6.7 South and Central America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6.7.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.6.8 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.6.8.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.6.8.2 Brazil: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.6.8.2.1 Brazil: Anti-Obesity Drugs Market Breakdown, by Type
12.6.8.2.2 Brazil: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.8.2.2.1 Brazil: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.8.2.3 Brazil: Anti-Obesity Drugs Market Breakdown, by Application
12.6.8.2.4 Brazil: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.8.2.5 Brazil: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6.8.3 Argentina: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.6.8.3.1 Argentina: Anti-Obesity Drugs Market Breakdown, by Type
12.6.8.3.2 Argentina: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.8.3.2.1 Argentina: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.8.3.3 Argentina: Anti-Obesity Drugs Market Breakdown, by Application
12.6.8.3.4 Argentina: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.8.3.5 Argentina: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6.8.4 Rest of South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.6.8.4.1 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Type
12.6.8.4.2 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.8.4.2.1 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.8.4.3 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Application
12.6.8.4.4 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.8.4.5 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.2 North America
12.2.1 North America Anti-Obesity Drugs Market Overview
12.2.2 North America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.2.3 North America: Anti-Obesity Drugs Market Breakdown, by Type
12.2.3.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.2.4 North America: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.4.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.2.4.1.1 North America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.5 North America: Anti-Obesity Drugs Market Breakdown, by Application
12.2.5.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.2.6 North America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.6.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.2.7 North America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.2.7.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.2.8 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.2.8.1 North America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.2.8.2 United States: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.8.2.1 United States: Anti-Obesity Drugs Market Breakdown, by Type
12.2.8.2.2 United States: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.8.2.2.1 United States: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.8.2.3 United States: Anti-Obesity Drugs Market Breakdown, by Application
12.2.8.2.4 United States: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.8.2.5 United States: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.2.8.3 Canada: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.8.3.1 Canada: Anti-Obesity Drugs Market Breakdown, by Type
12.2.8.3.2 Canada: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.8.3.2.1 Canada: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.8.3.3 Canada: Anti-Obesity Drugs Market Breakdown, by Application
12.2.8.3.4 Canada: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.8.3.5 Canada: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.2.8.4 Mexico: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.2.8.4.1 Mexico: Anti-Obesity Drugs Market Breakdown, by Type
12.2.8.4.2 Mexico: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.2.8.4.2.1 Mexico: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.2.8.4.3 Mexico: Anti-Obesity Drugs Market Breakdown, by Application
12.2.8.4.4 Mexico: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.2.8.4.5 Mexico: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3 Europe
12.3.1 Europe Anti-Obesity Drugs Market Overview
12.3.2 Europe: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.3.3 Europe: Anti-Obesity Drugs Market Breakdown, by Type
12.3.3.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.3.4 Europe: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.4.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.3.4.1.1 Europe: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.5 Europe: Anti-Obesity Drugs Market Breakdown, by Application
12.3.5.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.3.6 Europe: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.6.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.3.7 Europe: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.7.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.3.8 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.3.8.1 Europe: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.3.8.2 Germany: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.2.1 Germany: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.2.2 Germany: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.2.2.1 Germany: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.2.3 Germany: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.2.4 Germany: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.2.5 Germany: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.3 United Kingdom: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.3.1 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.3.2 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.3.2.1 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.3.3 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.3.4 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.3.5 United Kingdom: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.4 France: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.4.1 France: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.4.2 France: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.4.2.1 France: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.4.3 France: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.4.4 France: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.4.5 France: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.5 Spain: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.5.1 Spain: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.5.2 Spain: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.5.2.1 Spain: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.5.3 Spain: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.5.4 Spain: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.5.5 Spain: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.6 Italy: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.6.1 Italy: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.6.2 Italy: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.6.2.1 Italy: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.6.3 Italy: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.6.4 Italy: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.6.5 Italy: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.3.8.7 Rest of Europe: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.3.8.7.1 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Type
12.3.8.7.2 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.3.8.7.2.1 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.3.8.7.3 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Application
12.3.8.7.4 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.3.8.7.5 Rest of Europe: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4 Asia Pacific
12.4.1 Asia Pacific Anti-Obesity Drugs Market Overview
12.4.2 Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.4.3 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Type
12.4.3.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.4.4 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.4.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.4.4.1.1 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.5 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Application
12.4.5.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.4.6 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.6.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.4.7 Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.7.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.4.8 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.4.8.1 Asia Pacific: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.4.8.2 China: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.2.1 China: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.2.2 China: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.2.2.1 China: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.2.3 China: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.2.4 China: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.2.5 China: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.3 Japan: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.3.1 Japan: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.3.2 Japan: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.3.2.1 Japan: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.3.3 Japan: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.3.4 Japan: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.3.5 Japan: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.4 India: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.4.1 India: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.4.2 India: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.4.2.1 India: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.4.3 India: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.4.4 India: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.4.5 India: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.5 Australia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.5.1 Australia: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.5.2 Australia: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.5.2.1 Australia: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.5.3 Australia: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.5.4 Australia: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.5.5 Australia: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.6 South Korea: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.6.1 South Korea: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.6.2 South Korea: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.6.2.1 South Korea: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.6.3 South Korea: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.6.4 South Korea: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.6.5 South Korea: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.4.8.7 Rest of APAC: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.4.8.7.1 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Type
12.4.8.7.2 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.4.8.7.2.1 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.4.8.7.3 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Application
12.4.8.7.4 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.4.8.7.5 Rest of APAC: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5 Middle East and Africa
12.5.1 Middle East and Africa Anti-Obesity Drugs Market Overview
12.5.2 Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.5.3 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Type
12.5.3.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.5.4 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.4.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.5.4.1.1 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.5 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Application
12.5.5.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.5.6 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.6.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.5.7 Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.7.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.5.8 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.5.8.1 Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.5.8.2 Saudi Arabia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.2.1 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.2.2 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.2.2.1 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.2.3 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.2.4 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.2.5 Saudi Arabia: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.8.3 South Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.3.1 South Africa: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.3.2 South Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.3.2.1 South Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.3.3 South Africa: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.3.4 South Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.3.5 South Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.8.4 United Arab Emirates: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.4.1 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.4.2 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.4.2.1 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.4.3 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.4.4 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.4.5 United Arab Emirates: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.5.8.5 Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.5.8.5.1 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Type
12.5.8.5.2 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.5.8.5.2.1 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.5.8.5.3 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Application
12.5.8.5.4 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.5.8.5.5 Rest of Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6 South and Central America
12.6.1 South and Central America Anti-Obesity Drugs Market Overview
12.6.2 South and Central America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
12.6.3 South and Central America: Anti-Obesity Drugs Market Breakdown, by Type
12.6.3.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Type
12.6.4 South and Central America: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.4.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Drug Class
12.6.4.1.1 South and Central America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.5 South and Central America: Anti-Obesity Drugs Market Breakdown, by Application
12.6.5.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Application
12.6.6 South and Central America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.6.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Route Of Administration
12.6.7 South and Central America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6.7.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
12.6.8 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.6.8.1 South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast Analysis - by Country
12.6.8.2 Brazil: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.6.8.2.1 Brazil: Anti-Obesity Drugs Market Breakdown, by Type
12.6.8.2.2 Brazil: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.8.2.2.1 Brazil: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.8.2.3 Brazil: Anti-Obesity Drugs Market Breakdown, by Application
12.6.8.2.4 Brazil: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.8.2.5 Brazil: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6.8.3 Argentina: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.6.8.3.1 Argentina: Anti-Obesity Drugs Market Breakdown, by Type
12.6.8.3.2 Argentina: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.8.3.2.1 Argentina: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.8.3.3 Argentina: Anti-Obesity Drugs Market Breakdown, by Application
12.6.8.3.4 Argentina: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.8.3.5 Argentina: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
12.6.8.4 Rest of South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
12.6.8.4.1 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Type
12.6.8.4.2 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Drug Class
12.6.8.4.2.1 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist
12.6.8.4.3 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Application
12.6.8.4.4 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration
12.6.8.4.5 Rest of South and Central America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel
13. Industry Landscape
13.1 Overview
13.2 New Product Development/Approval
13.3 Other Business Strategies
13.2 New Product Development/Approval
13.3 Other Business Strategies
14. Company Profiles
14.1 Novo Nordisk AS
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.2 Eli Lilly and Co
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GSK Plc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.4 Rhythm Pharmaceuticals Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Currax Pharmaceuticals LLC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 VIVUS LLC
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AdvaCare Pharma USA LLC
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.8 Teva Pharmaceutical Industries Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 F. Hoffmann-La Roche Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.2 Eli Lilly and Co
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GSK Plc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.4 Rhythm Pharmaceuticals Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Currax Pharmaceuticals LLC.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 VIVUS LLC
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AdvaCare Pharma USA LLC
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.8 Teva Pharmaceutical Industries Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 F. Hoffmann-La Roche Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
15.2 Glossary of Terms
List of Tables
Table 1. Anti-Obesity Drugs Market Segmentation
Table 2. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million)
Table 3. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million)
Table 4. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 5. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 6. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 7. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 8. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 9. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 10. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 11. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 12. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 13. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 14. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 15. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 16. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 17. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 18. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 19. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 20. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 21. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 22. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 23. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 24. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 25. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 26. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 27. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 28. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 29. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 30. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 31. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 32. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 33. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 34. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 35. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 36. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 37. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 38. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 39. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 40. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 41. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 42. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 43. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 44. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 45. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 46. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 47. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 48. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 49. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 50. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 51. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 52. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 53. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 54. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 55. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 56. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 57. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 58. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 59. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 60. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 61. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 62. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 63. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 64. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 65. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 66. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 67. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 68. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 69. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 70. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 71. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 72. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 73. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 74. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 75. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 76. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 77. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 78. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 79. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 80. ADULT OBESITY IN 2030
Table 81. CHILD OBESITY IN 2030
Table 82. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 83. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 84. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 85. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 86. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 87. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 88. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 89. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 90. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 91. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 92. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 93. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 94. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 95. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 96. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 97. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 98. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 99. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 100. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 101. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 102. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 103. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 104. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 105. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 106. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 107. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 108. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 109. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 110. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 111. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 112. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 113. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 114. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 115. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 116. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 117. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 118. ADULT OBESITY IN 2030
Table 119. CHILD OBESITY IN 2030
Table 120. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 121. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 122. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 123. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 124. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 125. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 126. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 127. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 128. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 129. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 130. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 131. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 132. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 133. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 134. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 135. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 136. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 137. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 138. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 139. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 140. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 141. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 142. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 143. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 144. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 145. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 146. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 147. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 148. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 149. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 150. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 151. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 152. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 153. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 154. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 155. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 156. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 157. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 158. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 159. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 160. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 161. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 162. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 163. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 164. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 165. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 166. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 167. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 168. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 169. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 170. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 171. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 172. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 173. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 174. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 175. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 176. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 177. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 178. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 179. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 180. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 181. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 182. ADULT OBESITY IN 2030
Table 183. CHILD OBESITY IN 2030
Table 184. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 185. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 186. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 187. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 188. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 189. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 190. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 191. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 192. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 193. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 194. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 195. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 196. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 197. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 198. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 199. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 200. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 201. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 202. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 203. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 204. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 205. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 206. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 207. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 208. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 209. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 210. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 211. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 212. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 213. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 214. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 215. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 216. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 217. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 218. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 219. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 220. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 221. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 222. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 223. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 224. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 225. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 226. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 227. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 228. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 229. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 230. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 231. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 232. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 233. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 234. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 235. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 236. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 237. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 238. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 239. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 240. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 241. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 242. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 243. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 244. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 245. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 246. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 247. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 248. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 249. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 250. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 251. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 252. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 253. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 254. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 255. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 256. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 257. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 258. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 259. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 260. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 261. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 262. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 263. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 264. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 265. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 266. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 267. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 268. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 269. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 270. ADULT OBESITY IN 2030
Table 271. CHILD OBESITY IN 2030
Table 272. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 273. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 274. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 275. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 276. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 277. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 278. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 279. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 280. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 281. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 282. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 283. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 284. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 285. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 286. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 287. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 288. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 289. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 290. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 291. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 292. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 293. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 294. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 295. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 296. ADULT OBESITY IN 2030
Table 297. CHILD OBESITY IN 2030
Table 298. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 299. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 300. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 301. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 302. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 303. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 304. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 305. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 306. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 307. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 308. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 309. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 310. South and Central America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 311. South and Central America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 312. South and Central America: Anti-Obesity Dru
Table 2. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million)
Table 3. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million)
Table 4. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 5. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 6. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 7. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 8. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 9. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 10. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 11. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 12. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 13. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 14. Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 15. Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 16. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 17. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 18. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 19. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 20. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 21. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 22. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 23. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 24. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 25. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 26. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 27. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 28. North America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 29. North America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 30. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 31. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 32. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 33. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 34. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 35. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 36. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 37. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 38. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 39. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 40. United States: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 41. United States: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 42. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 43. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 44. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 45. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 46. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 47. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 48. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 49. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 50. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 51. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 52. Canada: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 53. Canada: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 54. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 55. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 56. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 57. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 58. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 59. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 60. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 61. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 62. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 63. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 64. Mexico: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 65. Mexico: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 66. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 67. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 68. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 69. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 70. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 71. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 72. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 73. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 74. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 75. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 76. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 77. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 78. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 79. Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 80. ADULT OBESITY IN 2030
Table 81. CHILD OBESITY IN 2030
Table 82. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 83. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 84. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 85. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 86. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 87. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 88. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 89. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 90. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 91. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 92. Germany: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 93. Germany: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 94. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 95. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 96. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 97. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 98. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 99. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 100. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 101. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 102. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 103. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 104. United Kingdom: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 105. United Kingdom: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 106. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 107. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 108. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 109. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 110. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 111. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 112. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 113. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 114. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 115. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 116. France: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 117. France: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 118. ADULT OBESITY IN 2030
Table 119. CHILD OBESITY IN 2030
Table 120. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 121. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 122. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 123. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 124. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 125. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 126. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 127. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 128. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 129. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 130. Spain: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 131. Spain: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 132. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 133. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 134. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 135. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 136. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 137. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 138. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 139. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 140. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 141. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 142. Italy: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 143. Italy: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 144. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 145. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 146. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 147. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 148. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 149. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 150. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 151. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 152. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 153. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 154. Rest of Europe: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 155. Rest of Europe: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 156. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 157. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 158. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 159. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 160. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 161. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 162. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 163. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 164. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 165. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 166. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 167. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 168. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 169. Asia Pacific: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 170. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 171. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 172. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 173. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 174. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 175. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 176. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 177. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 178. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 179. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 180. China: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 181. China: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 182. ADULT OBESITY IN 2030
Table 183. CHILD OBESITY IN 2030
Table 184. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 185. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 186. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 187. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 188. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 189. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 190. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 191. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 192. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 193. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 194. Japan: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 195. Japan: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 196. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 197. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 198. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 199. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 200. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 201. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 202. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 203. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 204. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 205. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 206. India: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 207. India: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 208. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 209. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 210. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 211. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 212. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 213. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 214. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 215. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 216. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 217. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 218. Australia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 219. Australia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 220. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 221. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 222. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 223. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 224. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 225. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 226. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 227. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 228. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 229. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 230. South Korea: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 231. South Korea: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 232. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 233. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 234. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 235. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 236. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 237. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 238. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 239. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 240. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 241. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 242. Rest of APAC: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 243. Rest of APAC: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 244. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 245. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 246. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 247. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 248. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 249. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 250. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 251. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 252. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 253. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 254. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 255. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 256. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 257. Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 258. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 259. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 260. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 261. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 262. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 263. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 264. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 265. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 266. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 267. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 268. Saudi Arabia: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 269. Saudi Arabia: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 270. ADULT OBESITY IN 2030
Table 271. CHILD OBESITY IN 2030
Table 272. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 273. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 274. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 275. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 276. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 277. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 278. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 279. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 280. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 281. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 282. South Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 283. South Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 284. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 285. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 286. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 287. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 288. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 289. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 290. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 291. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 292. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 293. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 294. United Arab Emirates: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 295. United Arab Emirates: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 296. ADULT OBESITY IN 2030
Table 297. CHILD OBESITY IN 2030
Table 298. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 299. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 300. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
Table 301. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
Table 302. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Glp-1 Agonist
Table 303. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Glp-1 Agonist
Table 304. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 305. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 306. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Route Of Administration
Table 307. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route Of Administration
Table 308. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
Table 309. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
Table 310. South and Central America: Anti-Obesity Drugs Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 311. South and Central America: Anti-Obesity Drugs Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 312. South and Central America: Anti-Obesity Dru
List of Figures
Figure 1. Anti-Obesity Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Anti-Obesity Drugs Market Revenue (US$ Million), 2021-2031
Figure 5. Anti-Obesity Drugs Market Share (%) - by Type (2024 and 2031)
Figure 6. Prescription Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. OTC Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Anti-Obesity Drugs Market Share (%) - by Drug Class (2024 and 2031)
Figure 9. GLP-1 Agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lipase Inhibitors: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. MC4R agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Anti-Obesity Drugs Market Share (%) - by Application (2024 and 2031)
Figure 14. Appetite Suppression: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Inhibition of Fat Absorption or Digestive Enzymes: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Metabolic Enhancement: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Combination: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Anti-Obesity Drugs Market Share (%) - by Route Of Administration (2024 and 2031)
Figure 19. Oral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Parenteral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Anti-Obesity Drugs Market Share (%) - by Distribution Channel (2024 and 2031)
Figure 22. Hospital Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Online Channel: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Retail Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Anti-Obesity Drugs Market Breakdown by Region, 2024 and 2031 (%)
Figure 26. North America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 27. North America: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 28. North America: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 29. North America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 30. North America: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 31. North America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 32. North America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 33. North America: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 34. United States: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Canada: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 36. Mexico: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 37. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 38. Europe: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 39. Europe: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 40. Europe: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 41. Europe: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 42. Europe: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 43. Europe: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 44. Europe: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. Germany: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 46. United Kingdom: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. France: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 48. Spain: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 49. Italy: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 50. Rest of Europe: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 51. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 52. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 53. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 54. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 55. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 56. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 57. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 58. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 59. China: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 60. Japan: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 61. India: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 62. Australia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 63. South Korea: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 64. Rest of APAC: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 65. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 66. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 67. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 68. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 69. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 70. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 71. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 72. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 73. Saudi Arabia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 74. South Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 75. United Arab Emirates: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 76. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 77. South and Central America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 78. South and Central America: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 79. South and Central America: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 80. South and Central America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 81. South and Central America: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 82. South and Central America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 83. South and Central America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 84. South and Central America: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 85. Brazil: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 86. Argentina: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 87. Rest of South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Anti-Obesity Drugs Market Revenue (US$ Million), 2021-2031
Figure 5. Anti-Obesity Drugs Market Share (%) - by Type (2024 and 2031)
Figure 6. Prescription Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. OTC Drugs: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Anti-Obesity Drugs Market Share (%) - by Drug Class (2024 and 2031)
Figure 9. GLP-1 Agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lipase Inhibitors: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. MC4R agonist: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Anti-Obesity Drugs Market Share (%) - by Application (2024 and 2031)
Figure 14. Appetite Suppression: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Inhibition of Fat Absorption or Digestive Enzymes: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Metabolic Enhancement: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Combination: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Anti-Obesity Drugs Market Share (%) - by Route Of Administration (2024 and 2031)
Figure 19. Oral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Parenteral: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 21. Anti-Obesity Drugs Market Share (%) - by Distribution Channel (2024 and 2031)
Figure 22. Hospital Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Online Channel: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Retail Pharmacies: Anti-Obesity Drugs Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Anti-Obesity Drugs Market Breakdown by Region, 2024 and 2031 (%)
Figure 26. North America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 27. North America: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 28. North America: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 29. North America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 30. North America: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 31. North America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 32. North America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 33. North America: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 34. United States: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Canada: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 36. Mexico: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 37. Europe: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 38. Europe: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 39. Europe: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 40. Europe: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 41. Europe: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 42. Europe: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 43. Europe: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 44. Europe: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. Germany: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 46. United Kingdom: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. France: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 48. Spain: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 49. Italy: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 50. Rest of Europe: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 51. Asia Pacific: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 52. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 53. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 54. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 55. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 56. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 57. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 58. Asia Pacific: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 59. China: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 60. Japan: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 61. India: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 62. Australia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 63. South Korea: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 64. Rest of APAC: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 65. Middle East and Africa: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 66. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 67. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 68. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 69. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 70. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 71. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 72. Middle East and Africa: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 73. Saudi Arabia: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 74. South Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 75. United Arab Emirates: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 76. Rest of Middle East and Africa: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 77. South and Central America: Anti-Obesity Drugs Market - Revenue, 2021-2031 (US$ Million)
Figure 78. South and Central America: Anti-Obesity Drugs Market Breakdown, by Type (2024 and 2031)
Figure 79. South and Central America: Anti-Obesity Drugs Market Breakdown, by Drug Class (2024 and 2031)
Figure 80. South and Central America: Anti-Obesity Drugs Market Breakdown, by Glp-1 Agonist (2024 and 2031)
Figure 81. South and Central America: Anti-Obesity Drugs Market Breakdown, by Application (2024 and 2031)
Figure 82. South and Central America: Anti-Obesity Drugs Market Breakdown, by Route Of Administration (2024 and 2031)
Figure 83. South and Central America: Anti-Obesity Drugs Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 84. South and Central America: Anti-Obesity Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 85. Brazil: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 86. Argentina: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 87. Rest of South and Central America: Anti-Obesity Drugs Market - Revenue and Forecast, 2021-2031 (US$ Million)
Companies Mentioned
Some of the leading companies in the Anti-obesity Drugs Market include:- Novo Nordisk AS
- Eli Lilly and Co
- GSK Plc
- Rhythm Pharmaceuticals Inc
- Currax Pharmaceuticals LLC.
- VIVUS LLC
- AdvaCare Pharma USA LL
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd
- F. Hoffmann-La Roche Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 316 |
| Published | June 2025 |
| Forecast Period | 2024 - 2031 |
| Estimated Market Value ( USD | $ 15.85 Billion |
| Forecasted Market Value ( USD | $ 177.27 Billion |
| Compound Annual Growth Rate | 35.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
